David Sirois | Director of Corporate Accounting & SEC Reporting |
Jim Green | President & Chief Executive Officer |
Mike Rossi | Chief Financial Officer |
Bruce Jackson | The Benchmark Company |
Paul Knight | KeyBanc Capital Markets |
Good day, and thank you for standing by. Welcome to the Q2 2022 Harvard Bioscience, Inc. Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, David Sirois.